Business

Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds

Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrat...

articleCovalon Technologies Ltd.November 1, 20223/company/covalon-technologies-ltd/news/closing-chronic-wounds-with-collagen-powder-university-of-michigan-case-study-demonstrates-the-efficacy-of-colactive-plus-powder-in-resolving-non-healing-wounds
Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds

About this update from Covalon Technologies Ltd.

[{"type":"text","content":"\n \n \n \n Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Evidence on Covalon's New ColActive Plus Powder presented at the Symposium on Advanced Wound Care\n \n \n \n \n \n MISSISSAUGA, ON\n \n \n ,\n \n \n Nov. 1, 2022\n \n \n /CNW/ - Covalon Technologies Ltd. (the \"Company\" or \"Covalon\") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that its newest advanced wound care product, ColActive Plus Powder, was showcased in a case study presentation at the Symposium on Advanced Wound Care (SAWC), from\n \n October 13 to 16, 2022\n \n in\n \n Las Vegas\n \n . The study, conducted by Dr.\n \n Alton Johnson Jr.\n \n , DPM, FACPM, DABPM, CWSP, at\n \n University of Michigan\n \n School of Medicine, demonstrates the efficacy of ColActive Plus Powder in treating chronic non-healing wounds.\n \n \n \n \n \n \n \n \n \n \"I've had success using the ColActive Plus Powder to close challenging stalled wounds. It's applicable to a range of wound types, offering the benefits of collagen in an advanced formulation suitable for chronic or acute wounds\", states Dr. Johnson. \"It's a unique product, the only collagen-based powder that is available with or without an antimicrobial.\"\n \n \n Chronic, hard-to-heal wounds fail to advance through the phases of healing in an orderly and timely manner, often becoming stalled in the inflammatory phase. Imbalances in important cellular mediators for healing perpetuate the cycle of chronicity, which can lead to severe complications such as infection or amputation, which have grave consequences on overall quality of life. ColActive Plus Collagen Powder was uniquely designed to optimize the wound environment while supporting native collagen and connective tissue growth to help clinicians break the cycle of chronicity.\n \n \n \"In just a short time on the market, ColA...

More updates from Covalon Technologies Ltd.